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Alteration of Enzyme Activity in Rat Liver Following the Acute and 
Chronic Administration of Nicotine. RUDDON, R. W., and COHEN, A. M. 
(1970). Toxicol. Appl. Pharmacol. 16, 613-625. The ip injection of nicotine 
(2 or 4 mg/kg) to rats produced an increase in tryptophan pyrrolase activity 
in liver within 2 hours after drug administration. The elevation in enzyme 
activity reached a peak at 4 hours after drug injection and returned toward 
control levels by 6 hours. Administration of 4 mg of nicotine per kilogram 
to rats 4 times a day for 3 consecutive days produced an elevation of 
ethylmorphine and norcodeine metabolism in postmitochondrial super- 
natant fractions from liver. The chronic administration of nicotine (5.9 
mg/kg/day) in the drinking water for 7 days produced an elevation in the 
metabolism of ethylmorphine, norcodeine, and aniline by liver microsomes. 
This increased enzyme activity was maintained for 5 weeks when nicotine 
was continued at that dose. However, if the dose was lowered below 4.4 mg/ 
kg/day, the increased activity was not maintained. The activities of trypto- 
phan pyrrolase and tyrosine transaminase were not altered by chronic drug 
treatment. An increase in the capacity of liver microsomes to synthesize pro- 
tein was observed when nicotine treatment was continued for 4 weeks. These 
data indicate (1) that an elevation of microsomal drug-metabolizing en- 
zymes can be achieved after the acute administration of nicotine, but only 
when convulsive doses are given several times a day, suggesting that the 
increased activity after acute drug treatment may be a stress-related event; 
and (2) that the chronic administration of nicotine can increase the activity 
of drug-metabolizing enzymes, possibly by inducing enzyme synthesis. 
In the past few years there has been a vast expansion of knowledge in the area of 
drug interactions. One aspect of the problem that has received particular attention is 
modification of the effects of drugs by the concurrent or previous exposure to other 
drugs and chemical agents which alter drug metabolism (Conney, 1967). In view of the 
prevalence of the smoking habit it is pertinent to know what effects exposure to tobacco 
smoke may have on the activity of drug-metabolizing enzymes. It is well known that 
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3,4-benzpyrene and various other polycyclic hydrocarbons which are found in tobacco 
smoke enhance the activity of drug-metabolizing enzymes (Conney, 1967). The effect 
of nicotine itself, or metabolites of nicotine, on the activity of enzymes involved in 
drug metabolism is less well established. Wenzel and Broadie (1966) reported that the 
administration of nicotine to mice caused a decrease in the period of ataxia produced 
by meprobamate and that the metabolism of meprobamate was increased in liver 
homogenates prepared from mice treated for 2 days with nicotine. Yamamoto et al. 
(1966) found that pretreatment of rats with large doses of nicotine (30-40 mg/kg ip) 
in corn oil produced an increase in 2-acetylaminofluorene metabolism and benzpyrene 
hydroxylase activity in the postmitochondrial supernatant from treated animals 24 
hours after drug administration. However, the metabolism of 2-acetylaminofluorene 
declined below control levels if nicotine was given for 2 or 3 days prior to enzyme 
assay. Beckett and Triggs (1967) have stated that the metabolism of nicotine was 
greater in smokers than in nonsmokers on the basis that the amount of unchanged 
nicotine excreted in the urine was less in smokers than in nonsmokers after the 
administration of nicotine by various routes. Whether this apparent increased metab- 
olism was due to nicotine or other constituents of tobacco smoke was not evident. In 
addition, Welch et al. (1968) have reported that enzymatic hydroxylation of 3,4- 
benzpyrene was elevated in placental tissue obtained from smokers when compared to 
tissue from nonsmokers. Moreover, treatment of pregnant rats with benzpyrene 
increased the activity of the hydroxylase in the placenta. Thus, it seemed that com- 
ponents of tobacco smoke other than nicotine may have produced this increase. 
The present study was undertaken to determine what effects the acute and chronic 
administration of nicotine have on the activity of various enzyme systems and the 
synthesis of nucleic acids and protein in rat liver. 
METHODS 
Acute Studies 
Male Sprague-Dawley rats (Spartan Farms, Lansing, Michigan), weighing 150-200 
g, were maintained in a temperature-controlled room with a constant light-dark cycle 
(7 hours of darkness, 17 of light per 24 hours) with access to food and water ad libitum. 
Animals were injected ip with saline or nicotine (base) and sacrificed by decapitation 
at the same time each morning (8-9 AM). The livers were immediately removed, placed 
in Dounce homogenizing tubes on ice, and homogenized. 
Tryptophan pyrrolase (EC 1.13.1.12) activity was assayed in whole homogenates by 
measuring the quantity of kynurenine produced (in the absence of exogenous hematin) 
according to the method of Feigelson and Greengard (1961). Drug-metabolizing 
enzymes were assayed in the 12,500 g supernatant fraction, prepared by homogeniza- 
tion in 4 volumes of a solution containing 0.25 M sucrose-l mM disodium EDTA and 
centrifugation of the homogenate at 12,500 g for 20 min at 0”. The N-dealkylation of 
ethylmorphine and 0-dealkylation of norcodeine were determined by a modification 
of the method of Rubin et al. (1964) in a 5-ml reaction mixture which contained: 
0.5 mmole of phosphate buffer (pH 7.4), 0.3 mmole of KCI, 10.5 pmoles of MgCl,, 
38 pmoles of semicarbazide hydrochloride, 6 pmoles of glucose 6-phosphate, 0.55 
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pmoles of NADP, 4 pmoles of ethylmorphine or norcodeine, and 12-15 mg of 12,500 g 
supernatant protein. The samples were incubated for 15 min at 37”, and the reactions 
were stopped by the addition of 0.4 ml of 70% perchloric acid. Metabolism was 
estimated by the production of formaldehyde, which was determined by a modification 
of the method of Nash (1953). Nicotine oxidase activity was assayed in a reaction 
mixture similar to that described above except that the mixture contained 10-4 M 
NADPH, 30-35 mg of 12,500 g supernatant protein, and 250 pg of nicotine as sub- 
strate. The mixtures were incubated for 30 min at 37”, and the disappearance of nico- 
tine was determined by the method of Hug, Tsujimoto, and Ruddon (to be published). 
Basically, the procedure involved the extraction of nicotine base into 15 ml of hexane 
from samples (3 ml) which had been brought to pH 11 with concentrated NH,OH. 
A lo-ml aliquot of the hexane phase was added to 5 ml of 0.1 N HCI. After shaking and 
centrifugation, the hexane was aspirated, and the absorbance at 259 nm of an aliquot 
of the aqueous phase was determined. Extraction of nicotine from tissue samples by 
this method was 99 f 5 %. 
Protein determinations were done by the method of Lowry et al. (1951). 
Statistical analyses were performed using Student’s t test. 
Chronic Studies 
Male rats, weighing 60-80 g, were started on the regimen. Nicotine base was dis- 
solved in the drinking water (40 mg/liter) and placed in amber bottles. Fresh nicotine 
solution was added to the drinking bottles each day throughout the study. Frequent 
spectrophotometric analysis of the drinking solutions after 24 hours’ storage indicated 
that nicotine was not destroyed under these conditions. Water consumption was 
monitored daily, and the average dose throughout the study was calculated on a 
mg/kg/day basis. A control group of animals of the same age, size, and sex was placed 
in a similar environment and allowed access to untreated drinking water ad libitum. 
Both groups of animals were maintained on Purina rat chow ad libitum. The nicotine- 
treated animals gained weight at a rate of 33 g/week, and the controls gained an 
average of 47 g/week over a 5-week study period. Both groups of animals maintained 
water consumption at relatively the same level (ml consumed/g/day) throughout the 
study. 
Animals were sacrificed at weekly intervals after the initiation of treatment. The 
livers were immediately excised and homogenized in 5 volumes of ice-cold 0.32 M 
sucrose containing 3 mM MgC&. The homogenate was centrifuged at 12,500 g for 20 
min, and the supernatant fraction was then centrifuged at 105,000 g for 2 hours in a 
Spinco 40 rotor at 0” to obtain the microsomal pellet. 
Metabolism of ethylmorphine and norcodeine was determined in microsomes by a 
modification of the method of George and Tephly (1968). Reaction mixtures (5 ml) 
contained 0.5 mmole of phosphate buffer (pH 7.4), 0.3 mmole of KCl, 10.5 pmoles of 
MgClz, 38 pmoles of semicarbazide hydrochloride, 6 pmoles of glucose 6-phosphate, 
2.2 pmoles of NADP, 4 pmoles of ethylmorphine or norcodeine, 2 units of glucose-6- 
phosphate dehydrogenase, and 10-12 mg of microsomal protein. The samples were 
incubated for 10 min at 37”, and formaldehyde production was determined as above. 
Aniline hydroxylation was measured in a 5-ml reaction mixture which contained: 0.3 
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mmole of Tris-HCl (pH 7.8), 0.26 mmole of KCI, 10 pmoles of MgC12, 6 pmoles of 
glucose 6-phosphate, 2.2 pmoles of NADP, 20 pmoles of aniline hydrochloride, 2 
units of glucose-6-phosphate dehydrogenase, and 10-12 mg of microsomal protein. 
The samples were incubated for 15 min at 37”, and the production of p-aminophenol 
was determined by the method of Kato and Gillette (1965). Tyrosine transaminase 
(EC 2.6.1.5) activity was measured in 105,OOOg supernatant by the method of Wurtman 
and Larin (1968). 
Purified nuclei were obtained by centrifugation through 2.4 M sucrose by the method 
of Pogo et al. (1966). RNA polymerase activity was assayed in nuclei by the method of 
Pogo et al. (1966) except that incubations were carried out for 4 min at 37” (incorpora- 
tion of ATP-i4C into RNA was linear for 6 min and was dependent on the presence of 
nucleoside triphosphates), and the nuclear sediments were filtered on Millipore filters 
after addition of trichloroacetic acid (TCA) and repeated washing. The filters were 
then dried overnight ; toluene scintillator was added, and the samples were counted in 
a Packard Tri-Carb liquid scintillation spectrometer. 
DNA template activity was determined using a DNA-RNA-protein complex iso- 
lated from rat liver by the method of Swingle and Cole (1966). The DNA complex 
isolated by this method, using p-aminosalicylate-phenol extraction, contained 30-60 % 
RNA, and l-10 % protein. The properties of this complex suggested that it was not an 
artifact of preparation and that the presence of this complex in liver is related to the 
rapid rate of protein and RNA synthesis in this tissue (Swingle and Cole, 1966). The 
template activity of this complex was assayed using partially purified RNA poly- 
merase (EC 2.7.7.6; Micrococcus lysodeikticus) and DNA polymerase (EC 2.7.7.7; 
Escher&&z coli) as previously described (Ruddon and Johnson, 1968). DNA deter- 
minations were performed by the method of Burton (1952). 
Protein synthesis was assayed in liver microsomes using a I-ml incubation mixture 
which contained (in pmoles unless otherwise indicated): 35 Tris-HCI, pH 7.6; 10 
MgC12; 25 KCl; 6 /3- mercaptoethanol, 250 sucrose; 2 ATP, 1 GTP, 10 phosphoenol- 
pyruvate, 0.1 each of 19 unlabeled amino acids, 0.5 ,uCi phenylalanine-i%, 7 units 
pyruvate kinase, and 0.5-1.0 mg each of microsomal and 105,000 g supernatant pro- 
tein. Polyuridylic acid (100 pg) was added to some of the samples. In the absence of 
poly U, incorporation of labeled phenylalanine was linear for 6-10 min, and incuba- 
tions were carried out for 5 min at 37”. With the addition of poly U, incorporation was 
linear for 20 min, and lo-min incubations were employed. The reactions were stopped 
with cold 5 % TCA, washed twice with 5 % TCA, heated to 80-90” for 20 min, and 
filtered on Millipore titers. The filters were dried overnight and counted as above. 
Materials 
Ethylmorphine and norcodeine were gifts from Merck and Co. Thymidine-2-14C-5’- 
triphosphate (30.3 mCi/mmole), adenosine- i4C (u.1.) 5’-triphosphate (440 mCi/ 
mmole), and L-tyrosine-3,5-3H (25 Ci/mmole) were purchased from New England 
Nuclear Corp. L-Phenylalanine-1% (u.1.) (15.3 mCi/mmole) was obtained from 
Nuclear-Chicago Corporation. RNA polymerase (M. lysodeikticus) was purchased 
from Miles Laboratories, Inc. DNA polymerase (E cdi) was prepared in our labora- 
tory as previously described (Ruddon and Johnson, 1968). 
EFFECT OF NICOTINE ON LIVER ENZYMES 617 
RESULTS 
E&xts of Acute Administrarion of Nicotine on Enzyme Actiuity 
Tryptophan pyrrolase (TP) and tyrosine transaminase (TT) are amino acid- 
metabolizing enzymes found in liver tissue and subject to several types of adaptive and 
regulatory mechanisms. The activity of these enzymes has been reported to be affected 
by hormones (Lin and Knox, 1957; Feigelson and Feigelson, 1965; Kenney et al, 
1967) level of substrate (Lin and Knox, 1957; Schimke, 1967) feeding schedule 
(Potter et al., 1966) inherent circadian rhythms (Potter et al., 1966; Wurtman el al., 
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FIG. 1. Effect of nicotine injection on tryptophan pyrrolase (TP) activity in rat liver. Nicotine 
(4 mg/kg) was injected ip into rats, and the animals were sacrificed at various times after injection. 
TP was assayed as described in the Methods. Values represent mean &SE for 4-6 animals at each 
point. 
norepinephrine levels (TT only) (Black and Axelrod, 1968). Induction by corticoster- 
oids has been shown to involve the synthesis of new RNA (Peterkofsky and Tomkins, 
1968) presumably involving a “derepression” mechanism. There is some evidence that 
regulation of the activities of these two enzymes can also take place at the level of 
translation of mRNA into protein (Kenney et al,, 1967; Tomkins et al., 1965). It was 
thought that if the administration of nicotine altered processes that affected control 
mechanisms in liver, monitoring of these two enzymes might serve as a useful tool to 
detect these alterations. Figure 1 illustrates the levels of TP after the acute administra- 
tion of 4 mg of nicotine per kilogram. The activity of the enzyme appeared to reach a 
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activity was noted after 2 mg/kg of nicotine. The kinetics of elevation of TP activity 
are suggestive of adrenocorticosteroid release; the ip administration of cortisone or 
hydrocortisone produces an increase in liver TP activity which is remarkably similar 
(Feigelson and Feigelson, 1965). Both 2 and 4 mg/kg doses of nicotine produced 
convulsions in the rats, and it is likely that a pronounced effect on the adrenocortical- 
hypothalamic-pituitary axis also occurred. 
The effects of the injection of 2 or 4 mg/kg of nicotine 4 times a day for up to 3 days 
on TP and various drug-metabolizing enzymes are shown in Table 1. TP activity was 
significantly elevated above control at 72 hours after drug treatment was begun with a 
daily dose of 8 mg/kg. The metabolism of ethylmorphine (EM) was increased at 45 
and 72 hours after the initiation of treatment, but only with the 4 mg/kg dose. The 
O-dealkylation of norcodeine (NC) was elevated above control at 72 hours by both the 
TABLE 2 
EFFECT OF DIRECT ADDITION OF NICOTINE TO 12,500 g SUPERNATANT ON THE 
ACTIVITY OF DRUG-METABOLIZING ENZYMES’ 
Concentration of N-Dealkylation of O-Dealkylation of 
nicotine ethylmorphine norcodeine 
(M) (~~moles/mg protein/min) (p*CLmoles/mg protein/min) 
~~--- .- 
0 850 439 
10-j 455 228 
10-4 900 333 
10-Z 861 472 
a Activities were assayed in duplicate samples of 12,500g supernatant fractions prepared and pooled 
from the livers of two animals. 
2 and 4 mg/kg doses. Nicotine metabolism was not significantly increased above con- 
trol at any of the times examined. Thus the microsomal enzymes responsible for 
metabolism of these drugs appeared to be increased only after convulsive doses of 
nicotine, and the elevations that were seen may reflect a response to stress brought 
about by repeated injection of such large doses of drug. It should be noted that when 
nicotine was administered once a day ip (2 or 4 mg/kg) or SC in peanut oil (15 or 30 
mg/kg) for 3 consecutive days, no elevation of drug-metabolizing enzymes was ob- 
served. 
The direct addition of nicotine to the 12,500 g supernatant fraction (Table 2) had 
little effect on the metabolism of EM or NC except at the highest concentration 
employed (lo-3 M), at which concentration there was a depressant effect. Assuming 
uniform distribution of a 4 mg/kg dose of nicotine, a concentration of 2.5 x 10-S M 
could conceivably be achieved in vivo; however, there were no marked effects of nico- 
tine on EM or NC metabolism when nicotine was added to the reaction mixtures in 
this concentration range. This could be interpreted to mean that the observed aug- 
mentation of drug-metabolizing enzyme activity was due to something other than an 
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Efects of Chronic Administration qf Nicotine on Enzyme Activity, Nucleic Acid 
Synthesis, and Protein formation 
The chronic oral administration of nicotine produced an elevation of both EM and 
NC metabolism in liver microsomes (Table 3). An average dose of 5.9 i 0.3 mg/kg/ 
animal/day was maintained throughout Study I. The increased activity was apparent 
TABLE 4 
EFFECT OF CHRONIC NICOTINE ADMINISTRATION ON THE ACTIVITY OF 
TRYPTOPHAN PYRROLASE AND TYROSINE TRANSAMINASE IN RAT LIVER’ 
Tryptophan pyrrolase Tyrosine transaminase 
Duration of 
(~~moles kynurenine (ppmoles PHPPA* 
treatment 
formed/mg protein/min) formed/mg protein/min) 
-.~ 
(weeks) Control Treated- Control Treated 
2 176 rt 10 176*8 66oi50 610 + 40 
3 224 f  12 185~118 590 * 40 650 zt 20 
a Values are expressed as mean &SE for 4-8 animals per group. 
* p-Hydroxyphenylpyruvic acid. 
after 1 week of drug administration and was still evident when the animals were 
treated for 4-5 weeks. A second study was initiated, again starting with a dose of 
5.9 mg/kg/day. After 1 week of treatment there was about a 40% increase above 
controls in the metabolism of EM, NC, and aniline by liver microsomes. However, 
when the dose was lowered to 4.4 mg/kg/day during the second week of treatment, the 
elevation of activity of drug-metabolizing enzymes diminished. During the third week 
the dose was lowered to 3.5 mg/kg, and the elevated activity previously observed in the 
nicotine-treated rats essentially disappeared. Thus, apparently a daily dose of 4.4 
mg/kg or greater of nicotine is needed to produce an elevation in the ability of liver 
microsomes to metabolize drugs. 
TABLE 5 
EFFECT OF CHRONK NICOTINE ADMINISTRATION ON NUCLEIC ACID SYNTHESIS* 
DNA template DNA template 
RNA synthesis in activity in RNA activity in DNA 
Duration of 
purified nuclei polymerase system polymerase system 
nicotine 
(ppmoles ATPJ4C (mpmoles UTP-1°C (mpmoles TTPJ4C 
administration 
incorporated/mg DNA) incorporated/mg DNA) incorporated/mg DNA) 
(weeks) Control Treated Control Treated Control Treated 
1 122 106 3.73 2.76 108 112 
2 105 114 1.98 1.88 153 155 
4 125 131 - - - - 
5 120 121 2.10 2.43 108 92 
a Values represent the mean for triplicate assays performed with nuclei or DNA samples pooled 
from nicotine treated (68) or control (4-6) animals. 
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The data in Table 4 indicate that the chronic administration of nicotine (5.9 mg/kg/ 
day) did not significantly alter the activities of tryptophan pyrrolase or tyrosine 
transaminase, two enzymes that are responsive to a number of environmental and 
metabolic stimuli. 
The ability of purified nuclei and partially purified DNA to synthesize nucleic acids 
and the capacity of liver microsomes to fabricate proteins were also examined during 
the chronic administration of nicotine (5.9 mg/kg/day). The data in Table 5 indicate 
that nuclear RNA synthesis was not markedly altered by chronic nicotine administra- 
tion. The template ability of the DNA-protein complex isolated from livers of control 
and treated animals also was not significantly different after 5 weeks of drug admini- 
stration. However, there was an elevation of protein synthesis by liver microsomes 4 
weeks after the initiation of treatment (Table 6). At that time, there was a 30-40x 
TABLE 6 
EFFECT OF CHRONIC NICOTINE ADMINISTRATION ON in F&w PROTEIN SYNTHESIS 
IN MICROSOMAL FRACTION FROM RAT LIVER 
Duration of Count/min phenylalanine-1% incorporated/mg protein 
nicotine 
administration Endogenous messenger +Poly u 
(weeks) Control Treated Control Treated 
1 47 34 157 115 
2 25 18 99 101 
4 99” 130 251 359 
E Specific activity of labeled amino acid was increased to achieve higher incorporation of radio- 
activity. 
stimulation of polypeptide formation both by endogenous messenger and in the 
presence of added poly U. The direct addition of nicotine in concentrations of IO-5 to 
10-3 M to the in vitro reaction mixtures had no significant effect on nuclear RNA 
synthesis, DNA template activity, or microsomal protein synthesis. 
DISCUSSION 
The results of this study indicate that the acute and chronic administration of nico- 
tine to rats can produce elevations of enzymatic activity in liver tissue. The observation 
that the peak increase in TP activity occurred at 4 hours after the acute ip administra- 
tion of nicotine suggested that this action of the drug might be related to corticosteroid 
release. Recently, however, Magus et al. (1968) have reported that the subcutaneous 
injection of nicotine (2 mg/kg at 0 time and again 2 hours later) produced a slight but 
statistically significant activation of TP in adrenalectomized rats when measured 4 
hours after the initial injection. Thus, part of our observed effects might be due to 
other direct or indirect effects of nicotine on TP levels in liver. At any rate, it should be 
emphasized that in our studies, increases in drug-metabolizing enzymes after acute 
nicotine administration were only observed when convulsive doses were administered 
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four times a day. Therefore, the “stress” produced by injection of such large doses of 
nicotine might have been responsible for the elevations of drug-metabolizing enzyme 
activity noted after treatment for 48 or 72 hours. There is evidence that stressful 
environmental manipulations or the injection of corticosteroids can increase the 
capacity of liver microsomes to metabolize drugs (Furner and Stitzel, 1968; Arrhenius, 
1968). 
When nicotine was given chronically in a dose of 5.9 mg/kg/day in the drinking 
water so that the drug was administered over a 24-hour period in a more even way, no 
apparent toxicity was noted. It should be pointed out that nicotine is readily absorbed 
after oral administration (Goodman and Gilman, 1965). This treatment schedule 
would also be expected to maintain blood and tissue levels of nicotine over a more 
prolonged period of time than the acute ip injections. The results of these studies 
indicated that when nicotine is given chronically, an increase in the activity of certain 
microsomal drug-metabolizing enzyme systems can be produced. The magnitude of 
these elevations was in the order of 25-50x, and the increased activity could not be 
maintained when the average daily dose was lowered below 4.4 mg/kg. Thus, nicotine 
when given chronically in doses of this magnitude is a relatively weak “inducing 
agent” when compared to phenobarbital or certain polycyclic hydrocarbons (Conney, 
1967). As a point of comparison, a human who smokes 1 pack of cigarettes a day 
absorbs about 1 mg/kg/day and a 2-pack-a-day smoker absorbs about 2 mg/kg/day 
(Larson et al., 1961). Thus, a dose of 5-6 mg/kg/day in a rat would not seem to be an 
unreasonable comparison. Furthermore, even though nicotine appears to be a rela- 
tively weak “inducer,” the combination of nicotine with the polycyclic hydrocarbons 
found in tobacco smoke may result in a significant elevation of certain microsomal 
drug-metabolizing enzymes in individuals that are prone to the smoking habit. 
The possibility also exists that various metabolites of nicotine may play a role in the 
alterations of liver enzyme activity noted in these studies. For example, Yamamoto 
ef al. (1966) reported that cotinine, an oxidative metabolite of nicotine, was about as 
potent as nicotine (when the drugs were given in doses of 40 mg/kg) in the ability to 
increase benzpyrene hydroxylase activity in rat liver. However, preliminary experi- 
ments in our laboratory indicate that no significant alteration of microsomal enzymes 
occurs when cotinine is administered chronically in the drinking water at doses of 
5-6 mg/kg/day. 
It is not clear at this point whether nicotine is acting as an “inducing” agent (i.e., 
increasing the amount of enzyme present) or as an “activating” agent which stimulates 
the function of a key component, without stimulating its synthesis or inhibiting its 
degradation, in the drug metabolism system. The observation that chronic nicotine 
treatment can increase the capacity of liver microsomes to synthesize protein indicates 
that nicotine has the potential to act as an inducing agent. In addition, Yamamoto 
et al. (1966) have reported that the increased activity of microsomal drug-metabolizing 
enzymes noted in rat liver after acute nicotine treatment (40 mg/kg) was bIocked by 
prior administration of ethionine. 
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